Latine
Home > Products > Dabigatran API

Sinae Dabigatran API Factory

Sandoo magnus Dabigatran API fabrica et praebitus in Sinis est. Officina nostra in Dabigatran API exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.

Related Products

Hot Products

  • 2,4-Thiazolidinedione

    2,4-Thiazolidinedione

    Product Name:2,4-Thiazolidinedione
    Formulae hypotheticae: C3H3NO2S
    Molecular pondus:117.13
    CAS Subcriptio Number:2295-31-0
  • Cinepazide Maleate

    Cinepazide Maleate

    Product Name: Cinepazide maleate
    Formulae hypotheticae: C26H35N3O9
    M. Pondus; 533.57
    CAS Subcriptio Number: 26328-04-1
  • 3-(4-Chlorbutyl) -1H-indol-5-carbonitril

    3-(4-Chlorbutyl) -1H-indol-5-carbonitril

    Product Name:3-(4-Chlorbutyl) -1H-indol-5-carbonitril
    Formulae hypotheticae: C13H13ClN2
    Molecular pondus:232.71
    CAS Registry Number: 143612-79-7
  • Irinotecan hydrochloride trihydratorum

    Irinotecan hydrochloride trihydratorum

    Product nomen: Irinotecan hydrochloride trihydratorum
    Formulae hypotheticae: C33H45ClN4O9
    Molecular pondus:677,18
    CAS Registry Number: 136572-09-3
  • (R, R) -1,2-bis (methanesulfonyloxymethyl)

    (R, R) -1,2-bis (methanesulfonyloxymethyl)

    Product Name:(R,R)-1,2-bis(methanesulfonyloxymethyl)cyclohexane
    Formulae hypotheticae: C10H20O6S2
    Molecular pondus: 300.39
    CAS Subcriptio Number:186204-35-3
  • Fmoc-Gln(Trt)-OH

    Fmoc-Gln(Trt)-OH

    Product Name:Fmoc-Gln(Trt)-OH
    Formulae hypotheticae: C39H34N2O5
    Molecular pondus:610.7
    CAS Subcriptio Number:132327-80-1
  • Related Blog
  • Recognitiones

  • Quid est pharmaceuticum activum Ingrediens (API in Pharma)?

    Sandoo pharmaceutica est professionalis activus pharmaceuticus medius opifex, qualitatem APIs altam producens. Sandoo pharmaceutica amplis intermedia pharmaceutica activa praebet.

  • Tofacitinib Plus efficax, Sola & in Combinationibus, quam Non-biologicis DMARDS

    Tofacitinib (venales notae nomine Xeljanz) inhibitor oralis Janus kinasus nunc probatus est pro curatione RA. Unico publico-privata societate inter National Instituta Salutis... evoluta est.

  • Pharmaceutical Intermedia Manufacturers - Aliquid debes scire de Pharma media Industry

    Media pharmaceutica sunt actu chemicae materiae rudis vel chemicae productae quae in synthesi medicamentorum adhibenda sunt. Tales fructus chemicas in plantis chemicis ordinariis produci possunt sine licentia productionis pharmaceuticae. Quamdiu indicibus technicis ad certa momenta requisita conveniant, adhiberi possunt synthesim et productionem medicamentorum participare.

  • Cancer prostatae et Darolutamide

    cancer prostatae consequitur ex impotenti incremento cellularum cancri in glandula prostatae. Glandula prostatae infra vesicam et ante rectum intestinum sita est, nec nisi in maribus invenitur. Fere omnes carcinomata prostatae (plus quam 95% carcinomata prostatae primarum) ex cellulis glandularum evulsis et adenocarcinomata cognoscuntur (Cancer Institutum Nationale, 2017).

  • What Is Ursodeoxycholic Acid Used For?

    Acidum ursodeoxycholicum cholelithiantum communiter in genere gastroenterologiae adhibitum est, et etiam cholelithiasis agentis dissolventis, ut in curatione fel lapidum in adiunctis normalibus adhiberi potest, praemissa.

  • Quae differentia est inter API et FDF in pharma？.

    In industria pharmaceutica, vocabula "FDF" et "API" frequenter adhibita in productis audies. Certo hoc genus inconditae intellegimus, sed certe perspicimus quomodo publicum generale gravetur inspiciendo illas abbreviationum terminorum species. Hic articulus est ad explicandam differentiam inter API et FDF. Referunt enim, respective significant formam dosis perfectam et medicamentum pharmaceuticum activum.

Mitte Inquisitionem

Percute Enter ad quaerere vel ESC ad claudere
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept